•An EMA committee adopted a positive opinion backing Gilead's Trodelvy in combination with Merck's Keytruda for first-line advanced triple-negative breast cancer.
•An EU Commission spokesperson stated that ChatGPT and Roblox could be included in the list of very large online platforms under the Digital Services Act.
•Johnson & Johnson cut its 2026 profit forecast, citing the financial impact of its acquisition of Firefly Bio and a partnership with Sail Biomedicines.